Sara Harrysson

About me
Publications
CV
Public outreach and news

About me

I am a board certified specialist in Hematology working part time as a
clinician at the Hematology department at Karolinska University Hospital in
Solna. In the clinic I see mainly patients with different types of lymphoma
and acute lymphoblastic leukemia. I defended my thesis with the title: "
Diffuse large B-cell lymphoma: population-based studies of relapse and
cardiac complications in March 2023.
PhD Karolinska Institutet 2023
Specialist in Hematology 2018
Research School for Clinicians in Epidemiology 2015-2017
MD Karolinska Institutet 2007

Research

My research focus on the most common aggressive lymphoma type
Diffuse large
B-cell lymphoma (DLBCL). Based on data from the Swedish Lymphoma register I
investigate survival and risk of relapse of DLBCL as well as outcome for the
relapse patients. I also investigate timing and risk of cardiovascular events
after a DLBCL diagnosis.

Articles

Article: BRITISH JOURNAL OF CANCER. 2022;127(9):1642-1649

Patient trajectories after diagnosis of diffuse large B-cell lymphoma-a multistate modelling approach to estimate the chance of lasting remission.

Ekberg S; Crowther M; Harrysson S; Jerkeman M; E Smedby K; Eloranta S
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2022;198(2):267-277

Outcomes of relapsed/refractory diffuse large B-cell lymphoma and influence of chimaeric antigen receptor T trial eligibility criteria in second line-A population-based study of 736 patients.

Harrysson S; Eloranta S; Ekberg S; Enblad G; El-Galaly TC; Sander B; Sonnevi K; Andersson P-O; Jerkeman M; Smedby KE
Article: EJHAEM. 2021;2(4):774-784

Excellent survival after R-Hyper-CVAD in hospitalized patients with high-risk large B-cell lymphoma: The Karolinska experience.

Sonnevi K; Ljungqvist M; Jóelsson JK; Harrysson S; Wästerlid T; Bernell P; Wahlin BE
Article: JOURNAL OF INTERNAL MEDICINE. 2021;290(5):1048-1060

Myocardial infarction in diffuse large B-cell lymphoma patients - a population-based matched cohort study.

Ekberg S; Harrysson S; Jernberg T; Szummer K; Andersson P-O; Jerkeman M; Smedby KE; Eloranta S
Article: BLOOD CANCER JOURNAL. 2021;11(1):9

Incidence of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) including CNS relapse in a population-based cohort of 4243 patients in Sweden.

Harrysson S; Eloranta S; Ekberg S; Enblad G; Jerkeman M; Wahlin BE; Andersson P-O; Smedby KE
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2021;192(1):75-81

Survival of very elderly patients with diffuse large B-cell lymphoma according to treatment intensity in the immunochemotherapy era: a Swedish Lymphoma Register study.

Sonnevi K; Wästerlid T; Melén CM; Harrysson S; Smedby KE; Wahlin BE
Article: AMERICAN JOURNAL OF HEMATOLOGY. 2020;95(7):740-748

Outcome and determinants of failure to complete primary R-CHOP treatment for reasons other than non-response among patients with diffuse large B-cell lymphoma.

Wästerlid T; Harrysson S; Andersson TM-L; Ekberg S; Enblad G; Andersson P-O; Jerkeman M; Eloranta S; Smedby KE
Article: BIOMEDICINES. 2020;8(6):E170-170

ROR1 Is Expressed in Diffuse Large B-Cell Lymphoma (DLBCL) and a Small Molecule Inhibitor of ROR1 (KAN0441571C) Induced Apoptosis of Lymphoma Cells.

Ghaderi A; Daneshmanesh AH; Moshfegh A; Kokhaei P; Vågberg J; Schultz J; Olin T; Harrysson S; Smedby KE; Drakos E; Rassidakis GZ; Österborg A; Hojjat-Farsangi M; Mellstedt H

All other publications

KI thesis / dissertation: 2023

Diffuse large B-cell lymphoma : population-based studies of relapse and cardiac complications

Harrysson, Sara

Employments

Affiliated to Research, Department of Medicine, Karolinska Institutet, 2023-2024

Degrees and Education

Degree Of Doctor Of Philosophy, Department of Medicine, Solna, Karolinska Institutet, 2023
University Medical Degree, Karolinska Institutet, 2007

About me

Research

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI